BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26349750)

  • 1. Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer.
    Granato T; Manganaro L; Petri L; Porpora MG; Viggiani V; Angeloni A; Anastasi E
    Tumour Biol; 2016 Feb; 37(2):2177-81. PubMed ID: 26349750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the association between 25-OH vitamin D levels and ROMA score in a population of obese women.
    Anastasi E; Capoccia D; Granato T; Viggiani V; Tartaglione S; Manganaro L; Angeloni A; Leonetti F
    J Biol Regul Homeost Agents; 2016; 30(4):1165-1171. PubMed ID: 28078870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does vitamin D mediate inhibition of epithelial ovarian cancer by modulating cytokines?
    Mohapatra S; Saxena A; Gandhi G; Koner BC; Singh T; Ray PC
    Clin Transl Oncol; 2015 Aug; 17(8):590-5. PubMed ID: 25740667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein levels and its clinical significance of septin-9 and clusterin in peripheral blood of epithelial ovarian cancer patients].
    Lyu N; Yao H; Xiao T; Gao Y; Wu L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):679-84. PubMed ID: 26675395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer.
    Kristjansdottir B; Levan K; Partheen K; Sundfeldt K
    Gynecol Oncol; 2013 Oct; 131(1):52-8. PubMed ID: 23891789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.
    Kurosaki A; Hasegawa K; Kato T; Abe K; Hanaoka T; Miyara A; O'Shannessy DJ; Somers EB; Yasuda M; Sekino T; Fujiwara K
    Int J Cancer; 2016 Apr; 138(8):1994-2002. PubMed ID: 26595060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population.
    Richards A; Herbst U; Manalang J; Pather S; Saidi S; Tejada-Berges T; Tan K; Williams P; Carter J
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):493-7. PubMed ID: 26172511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of blood and salivary IEX-1 expression in diagnosis of epithelial ovarian carcinoma.
    Li Y; Tan C; Liu L; Han L
    J Obstet Gynaecol Res; 2018 Apr; 44(4):764-771. PubMed ID: 29431239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer.
    Webb PM; de Fazio A; Protani MM; Ibiebele TI; Nagle CM; Brand AH; Blomfield PI; Grant P; Perrin LC; Neale RE;
    Am J Clin Nutr; 2015 Jul; 102(1):109-14. PubMed ID: 25971716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.
    Guo N; Peng Z
    J Ovarian Res; 2017 Mar; 10(1):14. PubMed ID: 28284216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.
    Sallinen H; Heikura T; Laidinen S; Kosma VM; Heinonen S; Ylä-Herttuala S; Anttila M
    Int J Gynecol Cancer; 2010 Dec; 20(9):1498-505. PubMed ID: 21119365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
    Kotowicz B; Fuksiewicz M; Sobiczewski P; Spiewankiewicz B; Jonska-Gmyrek J; Skrzypczak M; Kowalska M
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling.
    Zhang H; Ge T; Cui X; Hou Y; Ke C; Yang M; Yang K; Wang J; Guo B; Zhang F; Lou G; Li K
    Mol Biosyst; 2015 Feb; 11(2):516-21. PubMed ID: 25424060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancer.
    Stiekema A; Lok CA; Kenter GG; van Driel WJ; Vincent AD; Korse CM
    Gynecol Oncol; 2014 Mar; 132(3):573-7. PubMed ID: 24418200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer.
    Manganaro L; Michienzi S; Vinci V; Falzarano R; Saldari M; Granato T; Viggiani V; Frati L; Anastasi E
    Oncol Rep; 2013 Nov; 30(5):2481-7. PubMed ID: 23970060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection.
    Angioli R; Capriglione S; Aloisi A; Ricciardi R; Scaletta G; Lopez S; Miranda A; Di Pinto A; Terranova C; Plotti F
    Ann Surg Oncol; 2015 Dec; 22(13):4217-23. PubMed ID: 25808099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
    Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
    Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.
    Cho HY; Park SH; Park YH; Kim HB; Kang JB; Hong SH; Kyung MS
    J Korean Med Sci; 2015 Dec; 30(12):1777-83. PubMed ID: 26713052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.